NASDAQ:LEXX

Lexaria Bioscience Stock Forecast

etoro logo Buy LEXX
*Your capital is at risk
$0.530
-0.0292 (-5.22%)
At Close: Jul 07, 2026
AI Analysis AI Analysis of LEXX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add LEXX to Watchlist?
Some Reasons Why To Add LEXX:
  • High gross margin of 100.0%
  • Low bankruptcy risk (Altman Z-Score: 6.66)
  • Lower volatility than the market (beta 0.34)
PDF

Lexaria Bioscience Corp. stock price fell more than -5.22% Tuesday closing at $0.530
(Updated on Jul 07, 2026)

Sell candidate since Jun 17, 2026 Loss -13.14%

The Lexaria Bioscience Corp. stock price fell by -5.22% on the last day (Tuesday, 7th Jul 2026) from $0.560 to $0.530. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 9.22% from a day low at $0.530 to a day high of $0.579. The price has fallen in 7 of the last 10 days and is down by -9.01% for this period. Volume has increased on the last day by 5 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 17 thousand shares were bought and sold for approximately $8.97 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.01% during the next 3 months and, with a 90% probability hold a price between $0.271 and $0.376 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LEXX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 0.0566%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lexaria Bioscience Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.554 and $0.596. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Lexaria Bioscience Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Lexaria Bioscience Corp. stock

Lexaria Bioscience Corp. finds support from accumulated volume at $0.530 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0489 between high and low, or 9.22%. For the last week, the stock has had daily average volatility of 6.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LEXX) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Lexaria Bioscience Corp. to open at $0.546, and during the day (based on 14 day Average True Range), to move between $0.507 and $0.553, which gives a possible trading interval of +/-$0.0457 (+/-9.00%) up or down from last closing price. If Lexaria Bioscience Corp. takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.530 (0.06%) than the resistance at $0.577 (8.77%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Lexaria Bioscience Corp. will release earnings BMO on Monday, July 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0600. We will update the financials statements for Lexaria Bioscience Corp., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.77% in the first trading day after earnings release.

Is Lexaria Bioscience Corp. stock A Buy?

Lexaria Bioscience Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.385 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $0.546 ( 3.05%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

LEXX Performance

Trading levels for LEXX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.595 12.27%
R2 0.577 8.75%
R1 0.565 6.57%
Price 0.530
S1 0.528 -0.474%
S2 0.516 -2.65%
S3 0.498 -6.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.659 24.27%
R2 0.610 14.99%
R1 0.577 8.77%
Price 0.530
S1 0.530 -0.0566%
S2 0 -
S3 0 -

FAQ

What is the symbol for Lexaria Bioscience Corp. Stock and on which exchange is it traded?
The symbol for Lexaria Bioscience Corp. is LEXX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lexaria Bioscience Corp. Stock?
Lexaria Bioscience Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lexaria Bioscience Corp. Stock?
Lexaria Bioscience Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lexaria Bioscience Corp. Stock.

What's the current price of Lexaria Bioscience Corp. Stock?
As of the end of day on the Jul 07, 2026, the price of an Lexaria Bioscience Corp. (LEXX) share was $0.530.

What is the 52-week high and low for Lexaria Bioscience Corp. Stock?
The 52-week high for Lexaria Bioscience Corp. Stock is $1.70 and the 52-week low is $0.463.

What is the market capitalization of Lexaria Bioscience Corp. Stock?
As of the Jul 07, 2026, the market capitalization of Lexaria Bioscience Corp. is 10.842M.

When is the next earnings date for Lexaria Bioscience Corp.?
The upcoming earnings date for Lexaria Bioscience Corp. is Jul 13, 2026.
Click to get the best stock tips daily for free!
ABOUT LEXARIA BIOSCIENCE CORP.
Lexaria Bioscience
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
12.69% Jun 29
OSIS
$218.29
1.16% Jun 26
NMRK
$15.02
3.86% Jun 24
TTEK
$28.04
11.09% Jun 23
NESR
$25.07
10.21% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE